The International Bone and Mineral Society gratefully acknowledges the support of its 2009 partners:
The Alliance for Better Bone Health | Amgen | Chugai Pharmaceutical
Lilly | Merck | Novartis | Nycomed | Teijin | Wyeth
Information about Procter & Gamble Pharmaceuticals is available at www.pgpharma.com.
Information about Sanofi aventis is available at www.sanofi-aventis.com.
Information about Amgen Inc. is available at www.amgen.com.
Chugai Pharmaceutical aspires for development of innovative drugs by integrating cutting-edge technologies into its unique drug discovery infrastructure. Funneling resources into prescription drugs, Chugai is pursuing research and development of antibody drug-centered biopharmaceuticals in five franchises; cancer, renal, cardiovascular, bone/joint, and transplantation/immunology/infectious diseases while actively working on the traditional chemical cynthesis drug discovery. Based on high ethical and moral standards for a life science enterprise, Chugai, with its Patient-First philosophy, is committed to contributing to society by developing innovative drugs enabling higher patients' QOL and better lives.
Additional information about Chugai is available at www.chugai-pharm.co.jp.
Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions. We are committed to providing answers that matter - through medicines and information - for some of the world's most urgent medical needs.
Additional information about Lilly is available at www.lilly.com.
Merck, Sharp, and Dohme, Inc. (MSD) is a global, research-driven pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human health products. MSD, the manufacturer of FOSAMAX® (alendronate sodium), is a leader in osteoporosis research and treatment.
Additional information about MSD is available at www.merck.com.
Information about Novartis is available at www.novartis.com.
Nycomed is a European pharmaceutical company. Rapidly expanding, Nycomed now operates in 19 European countries including Russia / CIS. We provide hospital/specialist products throughout Europe and GP & OTC products in selected markets. Within the field of osteoporosis, Nycomed is currently partnering with NPS pharmaceuticals on the development of full-length PTH (1-84) which stimulates growth of structurally-normal bone lost to the disease. This product is expected to further strengthen Nycomed’s existing osteoporosis position built through its Nycomed Calcium & Vitamin D3 portfolio.
If you want to learn more about us please visit our website: www.nycomed.com.
Information about Teijin is available at www.teijin-pharma.co.jp
Wyeth Pharmaceuticals is a major research-oriented pharmaceutical company with leading products in the areas of women’s health care, cardiovascular disease therapies, central nervous system drugs, musculosketetal therapies, infectious disease, hemophilia, oncology, and vaccines. As a world leader in women’s health care, the company is committed to women through ongoing research efforts and patient education programs.
Additional information about Wyeth is available at www.wyeth.com.
2009 BoneKEy Sponsors
Information about Amgen Inc. is available at www.amgen.com.
Information about Procter & Gamble Pharmaceuticals is available at www.pgpharma.com.
Information about Sanofi aventis is available at www.sanofi-aventis.com.
Information about Lilly is available at www.lilly.com.
Wyeth Pharmaceuticals is a major research-oriented pharmaceutical company with leading products in the areas of women’s health care, cardiovascular disease therapies, central nervous system drugs, musculosketetal therapies, infectious disease, hemophilia, oncology, and vaccines. As a world leader in women’s health care, the company is committed to women through ongoing research efforts and patient education programs.
Additional information about Wyeth is available at www.wyeth.com.
2009 Collective Membership Society Sponsors